Business
New Data Back Bictegravir for HIV/HBV in Asia 5e4s4s
HONG KONG, June 27, 2024 — Gilead Sciences, Inc. unveiled findings from two comprehensive studies examining the effectiveness and tolerability of the B/F/TAF single-tablet regimen for the treatment of adults with HIV who are treatment-naïve […]